NCI
Get informed when a big investor buys or sells
+ FollowOvervalued by 174.9% based on the discounted cash flow analysis.
| Market cap | $6.05 Million |
|---|---|
| Enterprise Value | $54.07 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.65 |
| Beta | -2.88 |
| Outstanding Shares | 508,000 |
| P/E Ratio | -93.37 |
|---|---|
| PEG | 31.21 |
| Price to Sales | 0.05 |
| Price to Book Ratio | 0.11 |
| Enterprise Value to Revenue | 0.47 |
| Enterprise Value to EBIT | 32.58 |
| Enterprise Value to Net Income | -134 |
| Total Debt to Enterprise | 0.93 |
| Debt to Equity | 0.89 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data